Soleno Therapeutics Inc (SLNO) SEC Filings — 2025
18 SEC filings for Soleno Therapeutics Inc (SLNO) in 2025.
Filings
- Soleno Therapeutics Enters Material Agreement, Creates Financial Obligation — 8-K · Nov 12, 2025
- SLNO Swings to Profit on VYKAT XR Launch, Cash Reserves Soar — 10-Q · Nov 4, 2025
- Solen Therapeutics Reports Director Changes and Compensation Adjustments — 8-K · Oct 14, 2025
- Soleno Therapeutics Files 8-K — 8-K · Sep 10, 2025
- Soleno Therapeutics Files 8-K — 8-K · Aug 18, 2025
- Soleno Therapeutics Files 8-K — 8-K · Aug 6, 2025
- Solenos Net Loss Widens 18% Amid R&D Surge; $100M Offering Boosts Cash — 10-Q · Aug 6, 2025
- Soleno Therapeutics Enters Material Definitive Agreement — 8-K · Jul 11, 2025
- Soleno Therapeutics Files 8-K on Operations — 8-K · Jul 10, 2025
- Soleno Therapeutics Files 8-K on Security Holder Vote Matters — 8-K · Jun 6, 2025
- Soleno Therapeutics Files 8-K on Operations and Financials — 8-K · May 7, 2025
- Solen Therapeutics Files Q1 2025 10-Q — 10-Q · May 7, 2025
- Solen Therapeutics Files Annual Proxy Statement — DEF 14A · Apr 22, 2025
- Soleno Therapeutics Changes Independent Auditor — 8-K · Apr 18, 2025
- Soleno Therapeutics Files 8-K on Financials — 8-K · Mar 26, 2025
- Solen Therapeutics Files 2024 10-K — 10-K · Feb 28, 2025
- Soleno Therapeutics Files 8-K on Financials — 8-K · Feb 27, 2025
- Soleno Therapeutics Announces Board and Executive Changes — 8-K · Jan 24, 2025